Skip to Main Content

Paper Details

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
Neurooncol Adv
3
2023
Author NameAffiliation
Amy B HeimbergerMalnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine
Benjamin M Ellingsonuniversity of california los angeles Brain Tumor Imaging Laboratory, University of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Brain Tumor Imaging Laboratory, University of California Los Angeles
Craig Gedye
  • 1 - 4

Datasets